For Researchers - Search Now For Contributors - Join Now

Leadership

Management Team

Christopher Ianelli

Christopher Ianelli, MD, PhD

Founder and Chief Executive Officer

Christopher Ianelli

Christopher Ianelli, MD, PhD

Founder and Chief Executive Officer

Chris conceptualized and founded iSpecimen in response to the precision medicine movement and the growing demand for biospecimens by life science researchers.  As CEO, he is responsible for the company’s growth, performance, and corporate direction.  Under his leadership, iSpecimen has become a dominant player in research sample procurement, recently developing and launching the industry’s first and only true marketplace platform connecting researchers with healthcare providers and biorepositories.

Prior to launching iSpecimen, Chris served as Managing Director at Leerink Partners (formerly Leerink Swann), a leading healthcare and life science investment bank, where he managed the expansion and delivery of services and directed strategy to develop new healthcare data and information assets for the firm. At Leerink, Chris launched Health Insight Technologies, a healthcare informatics company that was spun out of the firm as Humedica and acquired by UnitedHealth Group in 2013.

Prior to Leerink, Chris was a co-founder and Managing Director of Boston Medical & Scientific Advisors, a healthcare investment research firm ultimately acquired by Leerink. He received both his Ph.D. in Immunology and his M.D. from Tufts University and completed his residency training, including a year as Chief Resident, in Pathology at Brigham & Women’s Hospital and Harvard Medical School.

Jill Mullan

Jill Mullan

Chief Operating Officer

Jill Mullan

Jill Mullan

Chief Operating Officer

Jill is responsible for ensuring operational excellence throughout the company. In this position, she oversees iSpecimen’s supply partner programs and operations, human resources, marketing, corporate communications, and corporate strategy. She is also responsible for ensuring regulatory compliance, privacy and security across the company’s operations.

Jill has over 25 years of experience in operational management, strategy, and marketing. Before joining iSpecimen, Jill ran a consulting business to help companies develop business and product strategies, raise funds, create brands, and launch new products. Prior to that, Jill was on the founding team and Director of Marketing at Storigen Systems, where she built and ran the company’s marketing organization, developed the company’s brand identity, and launched several successful products. She was also the Director of Product Marketing and Management at Avid Technology, managing the P&L for Avid’s $400M editing product line. Jill graduated with distinction from Cornell University with a BS in electrical engineering and received her MBA from Stanford University.

Benjamin Bielak

Chief Information Officer

Benjamin Bielak

Chief Information Officer

Ben brings 25 plus  years of executive and senior information technology experience to iSpecimen. In his role at iSpecimen as Chief Information Officer, Ben is responsible for technology delivery and data strategy and services.  He most recently served as the Chief Information Officer at GNS Healthcare, a leading casual machine learning product and services company, and as Director of Academic Technology at Harvard University. Prior to his work at GNS and Harvard, Bielak was the Chief Information Officer at Dovetail Health, a high-growth product and services company focused on reducing costs through pharmacy-focused interventions. He previously held roles as Manager of Development and Integration at Boston Medical Center and Senior Manager of Technology at Sapient.

Bielak holds a Master of Business Administration degree from Bentley University, where his studies focused on change management, and a master’s degree from Boston University in computer science. He maintains two certifications, the College of Healthcare Information Management Executives (CHIME) Certified Healthcare Chief Information Officer (CHCIO) and the Health Information Management System Society (HIMSS) Certified Professional in Healthcare Information and Management Systems (CPHIMS).

David Wages, MD, PhD

Chief Medical Officer

David Wages, MD, PhD

Chief Medical Officer

David is responsible for ensuring that iSpecimen meets the medical research needs of customers. This includes ensuring that specimens are of the highest quality and that iSpecimen technology will continue to meet the increasingly sophisticated needs of the academic, pharmaceutical, and government research communities.

Prior to joining iSpecimen, David served as Senior Medical Director at Quintiles, the world’s largest clinical research organization, where he supported both large pharmaceutical companies as well as smaller biotech organizations in a wide variety of clinical oncology programs. David has worked in both start-up biotechs and large pharma. David began his career working on the clinical development of novel drug-device combinations for blood decontamination at Cerus Corporation. He then worked on clinical trials at Wyeth that led to the development of Xyntha®, a drug used to treat hemophilia. After a brief stint assisting institutional investors on healthcare technology opportunities at Leerink-Swann’s Medacorp, David then moved on to ARIAD Pharmaceuticals where he turned to cancer research, working on ARIAD’s mTOR inhibitor for solid tumors as well as initiating ARIAD’s phase I trial for chronic myeloid leukemia drug, Iclusig®. David next joined EMD Serono where he worked on phase I-III trials of immune-agents for oncology. David holds an MD and PhD from the University of Virginia School of Medicine where he focused on the basic science of oncology. He then completed a residency at the University of California, San Francisco and a fellowship in hematopathology at Boston’s Beth Israel hospital.

Eric Langlois

Eric Langlois

Senior Vice President of Sales & Business Development

Eric Langlois

Eric Langlois

Senior Vice President of Sales & Business Development

Eric is responsible for driving and managing all aspects of company sales and business development. In this position, he applies his strategic vision as well as day-to-day execution on initiatives related to revenue generation and account management.  He also plays a key role in analyzing and developing the supply partner network in order to meet the demands of iSpecimen’s rapidly expanding customer base.

Eric has amassed nearly 20 years of experience in the arena of preclinical sample collections and biobanking for translational research.  Before joining iSpecimen, Eric was Head of North American Sales for the ReproCell Group.  He helped build and manage a sales team driven by the demands of integrating four portfolio companies with products and services in Cellular Reprogramming, Stem Cells, 3D cell culture, and biospecimens.  Prior to that, he held rapidly increasing positions from Regional Sales Manager to VP of Sales with Genomics Collaborative, SeraCare Life Sciences, SeqWright, and BioServe.  For over a decade Eric and his teams have proven quite successful at driving revenue using a consultative, customer-centric approach.  Eric holds a BS in Biotechnology/Biochemistry from Worcester Polytechnic Institute.

Dawn Michelle

Dawn Michelle

Vice President of Supply Operations

Dawn Michelle

Dawn Michelle

Vice President of Supply Operations

Dawn and her team manage all aspects of supply operations at iSpecimen, from understanding researcher requirements through fulfillment, working closely with iSpecimen’s network of partner laboratories and biorepositories.

Dawn and her team are responsible for implementing iSpecimen’s technology at partner sites, ensuring each supplier’s data is properly harmonized to industry standards, and optimizing iSpecimen-related operations to run efficiently at each site.

Dawn has over 25 years of clinical laboratory management experience with an emphasis in regulatory oversight. Dawn was formerly the Director of Operations for the Partners Biorepository for Medical Discovery, where she was responsible for providing the Partners research community with a repository and related services to support clinical, translational, and basic science research programs. Prior to that she managed the implementation of a new laboratory information system for the blood transfusion service at Brigham and Women’s Hospital. She received a BS in Clinical Laboratory Science from Georgia State University earning MT(ASCP) certification. Later, she earned a Specialist in Blood Banking (SBB) certification. She holds an MS in Computer Information Systems from Boston University.

Emily Hubbard

Director of Site Management & Development

Emily Hubbard

Director of Site Management & Development

Emily leads the Site Development and Management Team at Specimen. The team works with clinical sites to identify and audit clinical partners, facilitate agreements, implement workflow and compliance measures as well as ongoing oversight of sites and protocols. This allows iSpecimen to access specimens from  patient populations our researchers require for their work.

Emily has worked in Life Sciences for 20 years. Her career began in molecular biology. She moved quickly from the lab into management of Technical and Customer Support and Sales for companies such as Research Genetics, Invitrogen/Life Technologies and Thermo Fisher Scientific. Emily shifted into clinical research six years ago managing a team of Clinical Research Coordinators as well as management of relationships at a vast network of Clinical Sites. She joined iSpecimen in 2016, based in Huntsville, AL.

Carly Lejnieks

Director of Marketing

Carly Lejnieks

Director of Marketing

Carly and her team are focused on bringing the unique iSpecimen offering to life science customers who are seeking streamlined, compliant solutions for procuring archived pathology, banked, and prospective or custom-collected human biospecimens. The team is also focused on engaging new partners interested in joining the iSpecimen network, enabling deep and far-reaching access to millions of human biospecimens and patients that have consented to donate them.

Carly has led marketing strategies, integrated programs, and high-growth initiatives for Life Science organizations for more than 20 years. Before joining iSpecimen, she worked as a marketing consultant for more than a decade serving clients in the healthcare and life science industries. Most recently, she managed global, digital marketing and eCommerce programs responsible for driving double-digit growth in the cell culture consumables division of Thermo Fisher Scientific.

Dave John

VP of Product Management

Dave John

VP of Product Management

Dave is responsible for the overall product management, strategy, and vision at iSpecimen.  In this role,  he works with customer, suppliers, and iSpecimen leadership to assess and align the market requirements into clear product roadmap and design that engineering can deliver.  He also helps lead the data team to ensure that we have the data and the product to support a world-class platform for specimen procurement.

Dave brings nearly two decades of experience in business development, product management and executive leadership to the challenge of helping researchers procure human biospecimens for their work.  Dave led product management at Decision Resources Group (DRG) and PerkinElmer Informatics (PKI) creating products that support Real World Evidence, Precision Medicine, and Translational Research for the Healthcare and Life Sciences industries.  Prior to that, Dave was a Senior Solutions Architect at Deloitte where he sold, designed, and delivered custom precision medicine and patient engagement solutions across the industry.

Dave earned bachelor’s degrees in chemistry and chemical engineering at Lehigh University and an MBA in finance at Northeastern University.

Wayne Vaz

Vice President of Growth & Corporate Development

Wayne Vaz

Vice President of Growth & Corporate Development

Wayne is responsible for corporate development activities across iSpecimen and works with the leadership team to develop and implement go-to-market strategies, key partnerships, and strategic initiatives designed to drive overall growth. 

During his career in the life sciences industry serving private and public companies, Wayne has held senior management roles in the areas of corporate development, business development and strategic planning, and technology and alliance with leading companies such as Millipore Corp., Serologicals Corp., Celliance, Intergen, and Canada Packers Biochemicals. Prior to joining iSpecimen, Wayne served as Vice President, Corporate & Business Development with AllCells, LLC. 

Much of Wayne’s work over 25+ years has focused on executing organic and inorganic growth strategies involving commercialization of cell-based products and technologies used in drug discovery and development, biopharmaceutical production, and manufacturing of cell and gene therapies. Wayne holds a H.B.Sc. Biochemistry from the University of Toronto.

Board of Directors

In addition to our Founder & CEO, Christopher Ianelli and our COO, Jill Mullan, the following individuals sit on iSpecimen’s board of directors:

Andrew Ross

Board Member

Andrew Ross

Board Member

Andrew is a lifelong entrepreneur and private investor with a focus on early stage investments in biotechnology, collaborative consumption, and cause-focused enterprise.

George “Bud” Scholl

Board Member

Bud has been an entrepreneur for most of his professional life.  He has primarily focused on purchasing and working out distressed assets across a variety of industries and asset types. He has developed and invested in financial, real estate, service and technology companies. Bud currently serves as the President and Chief Executive Officer of OneBlood, which was formed in 2012 as a result of a merger he organized, when he was Chairman and CEO of the Community Blood Centers of Florida, one of the three largest blood centers in the southeastern United States. Bud also currently serves as the mayor of the City of Sunny Isles Beach, Florida, where he was elected in 2014 after serving as City Commissioner for seven years. Bud is a graduate of the University of Florida and holds an engineering degree in computer science. In his leisure time, Bud enjoys skiing, boating, restoring old games, and playing guitar.

Advisors

Robert Babkowski, MD, FCAP

Chair of Pathology, Stamford Hospital

Andy Brooks, PhD

Chief Operating Officer, Rutgers University Cell and DNA Repository

Martin Ferguson, PhD

Consultant, National Cancer Institute

Bill O’Donnell

Chief Executive Officer, Blade

Ed Trautman, PhD

VP, Informatics, Analytics and Business Intelligence LabCorp

Jim Vaught, PhD

Editor in Chief, Biopreservation & Biobanking Journal

The iSpecimen Marketplace

Search for Samples and Data Today

Create a login in seconds, for free, with no obligation. Gain immediate access to our real-time sample inventory today.

Already signed up?  Login to search our updated inventory.

Sign Up to Search the Marketplace